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Intimate partner violence and temporomandibular joint 
disorder 
 
Running Title: IPV and TMD 
 
Abstract  
 
Objective: To assess the relationship between Intimate partner violence (IPV) (a highly 
prevalent form of domestic abuse) with the subsequent development of 
Temporomandibular joint disorder (TMD).   
Methods: A retrospective open cohort study using a UK primary care database was 
undertaken. 18,547 women exposed to IPV were matched by age to 74,188 unexposed 
women. Defined through clinical codes the outcome of interest was TMD, and adjusted 
incidence rates (aIRR) were used to describe the relationship after considering covariates of 
interest.      
Results: 94 individuals in the exposed group were clinically coded with TMD during the 
study period translating to an incidence rate (IR) or 1.59 per 1,000 person years. This was in 
comparison to 342 outcomes in the unexposed group (IR 1.21 per 1,000 person years). The 
unadjusted IRR was 1.31 (95% CI 1.04-1.65; p<0.020) and after adjustment for important 
covariates increased to 1.45 (95% CI 1.14-1.84; p<0.002). 
Conclusion: Our results suggest that the development of TMD may be associated with 
exposure to IPV in women.  
 
Clinical significance 
 
In the first cohort to do so, we have identified a moderate association between Intimate 
partner violence exposure and subsequent development of TMD. This highlights an 
opportunity for screening of abuse in individuals presenting with TMD.  
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Introduction 
 
Temporomandibular joint disorder (TMD) is the name given to a number of disorders 
affecting the temporomandibular joint, muscles of mastication surrounding the jaw and 
related structures [1]. In the United States, TMD have been identified as a common 
condition with self-reported estimates of prevalence affecting 5% of adults [2]. Previous 
estimates suggested the lifetime prevalence of TMD related pain was between 3-62% [3]. 
The pain caused by TMD can be debilitating for patients who experience it, affecting many 
aspects of their working and social life [4]. Therefore, it is important to have an 
understanding of the cause of the condition to highlight any suitable opportunities for 
intervention.  
The aetiology of TMD is multifactorial in nature, with risk factors thought to range from; 
individual genetic and sex-based (more common in females) factors, dental related causes 
including occlusion issues and bruxism, to stress, depression and anxiety related states [5]. 
There has been evidence to suggest that patients who have experienced TMD, may also 
present with functional and structural changes in the thalamus, somatosensory cortex and 
some have dysfunction in the pain inhibition systems [6].  
Of those patients who present with chronic pain initiated by TMD, some have an increase in 
generalised pain sensitivity, which can be characteristic of central sensitisation of the 
nervous system [7]. There has been extensive work exploring changes in the stress response 
following abuse (childhood and adulthood abuse), which are linked to the development of 
central sensitisation in somatic disorders which may include TMD in those experiencing 
chronic pain [8]. Older research suggested that individuals presenting with TMD did, 
although not statistically significantly differently, self-report a higher prevalence of 
physical/sexual abuse than individuals without TMD [9]. Another study suggested that 
individuals with TMD who had experienced physical or sexual abuse experienced worse 
TMD pain compared to other patients with TMD [10]. However, both of these studies are 
small and not generalisable to a wider population. Intimate partner violence (IPV) is a form 
of adulthood abuse which includes physical and sexual abuse but also extends to other 
forms of abuse including emotional abuse and neglect [11]. IPV is estimated to affect one in 
three women globally, and has a range of physical and psychological consequences [12,13]. 
The association between IPV and TMD has not been previously tested. Considering the 
prevalence of IPV, it is important to ascertain of the burden of TMD disease in this cohort in 
order to provide an opportunity to suggest intervention if required and also to provide 
further insight into aetiology of TMD exploring whether IPV is a risk factor. Therefore, our 
aim was to conduct a retrospective cohort study using UK primary care data to explore this 
relationship 
Materials and Methods 
 
We conducted a population based retrospective cohort study using ‘The Health 
Improvement Network’ (THIN) database. The THIN database captures electronic records of 
approximately 3.6 million UK based patients, which are deemed to be representative of the 
general population in demographic structure and comorbidity burden [14,15]. The database 
uses a clinical coding system hierarchy called Read codes [16] to categorise symptoms, 
diagnoses and clinical outcomes. The validity of such coding is dependent on the accuracy of 
the individual inputting the data on the system. The study period was between 1st January 
1995 to 1st December 2017. During this period, we highlighted all women with a Read code 
relating to being a survivor of IPV forming our exposed group (Read codes: 14X3.00, 
14X8.00, 14XD.00, 14XE.00 and 14XG.00). These individuals were then matched on age (+/- 
1 year) to four controls from the database who did not have IPV (unexposed group). Each 
individual in the exposed group, had an index date assigned to either the earliest date of 
exposure in the study period or was given as the study start date if their exposure was prior 
to the study start date. The same index date was assigned to their counterpart in the 
unexposed group mitigating immortality time bias [17].  
The outcome measure was the development of TMD. This was deemed by the presence of a 
diagnostic Read Code of TMD (Read codes: J046.00, J046011, J046100, J046100, J046400 
and J046z00). If an individual in the exposed or unexposed group had the outcome of 
interest prior to their index date, they were excluded from the study. Baseline data relating 
to the individual’s alcohol use, smoking status, body mass index (BMI) and deprivation were 
also collected.  
Baseline data were described using means and proportions. Following this a Poisson 
regression was used to determine an incidence rate ratio (IRR) to describe the IRR of TMD 
comparing the exposed to the unexposed group. 95% confidence intervals are given with 
statistical significance set at p<0.05. An adjusted IRR (aIRR) Is also given which adjusts for 
other factors which may have an independent effect on TMD development which include 
age, smoking status, BMI and deprivation.  
Results 
 
The baseline characteristics of the group are described in table 1. 18,547 women with IPV 
exposure were matched to four controls in the unexposed group. However, 343 (1.9%) 
individuals in the exposed group had a pre-existing diagnosis of TMD as did 1,507 (2.0%) 
individuals in the unexposed group, therefore these individuals were then excluded from 
the main results presented in table 2. At study entry individuals in the exposed group had a 
higher prevalence of smoking, increased deprivation, increased prevalence of excessive 
drinking although reduced prevalence of non-excessive drinking and also marginally higher 
prevalence of individuals who were obese (>30kg/m2). 
During the study period, there were 94 incident outcomes of TMD in the exposed group 
which translated to an incidence rate (IR) or 1.59 per 1,000 person years. This was in 
comparison to 342 outcomes in the unexposed group (IR 1.21 per 1,000 person years). The 
unadjusted IRR was 1.31 (95% CI 1.04-1.65; p<0.020) and after adjustment for important 
covariates increased to 1.45 (95% CI 1.14-1.84; p<0.002). These results suggest that 
exposure to IPV is associated with the subsequent development of TMD. 
Conclusions 
 
This brief report summarises our new finding that incident TMD diagnosis is associated with 
IPV exposure in women (aIRR 1.45 (95% CI 1.14-1.84; p<0.002)), when tested in a UK cohort. 
We have also identified the IR of the development of TMD in an IPV cohort is 1.59 per 1,000 
person years.  
 
This type of study design presents with several limitations. The primary limitation relates to 
the accuracy of recording of both the exposure and outcome of interest. It is clear that the 
exposure (IPV) appears to be under recorded when compared to global estimates of IPV 
prevalence [12]. Although not directly comparable due to geographical variation and 
method of recording, when comparing the outcome (TMD) the overall prevalence of TMD in 
the control population is slightly lower than estimates in the US [2]. However, under 
recording of exposure is likely to mean we have possibly underestimated our effect size. We 
were unable to meaningfully explore a breakdown of the types of IPV (emotional, sexual, 
physical and neglect) due to the limited numbers of individuals recorded in these particular 
categories. We were also unable to explore the effect of the association on a breakdown of 
the different types of TMD, specifying what the causative factor was for the diagnosis. These 
should be explored in other cohorts to identify if there is either a dose-response 
relationship or different relationships appear depending on the type of abuse and type of 
TMD diagnosed.  
 
 
Considering the limitations of this study, our results pose particular significance as this is the 
first cohort globally to assess the outcome of incident TMD following exposure to IPV. 
Although we were unable to assess the severity of TMD pain symptoms nor define the 
nature of the abuse (emotional, physical sexual or neglect) we are able to confirm the 
relationship that exists suggesting that a history of abuse is associated with TMD [9,10]. This 
is of particular interest in terms of gaining further insight into the aetiology of TMD. As we 
excluded individuals with TMD prior to the start of the study, we were able to suggest the 
explore the temporality of the relationship by suggesting IPV exposure precedes TMD 
diagnosis. This is a relationship that needs to be tested in other cohorts to confirm this 
relationship. Also although we were unable to explore the biochemical relationship in this 
study, by defining the temporality of the relationship we can add to the debate surrounding 
whether it is possibly central sensitisation that occurs following abuse which could 
precipitate TMD in a subset of patients who experience chronic pain as a result of the 
diagnosis [8].  
 
In summary, in this study, we have been able to identify for the first time the relationship 
between TMD to exposure to IPV in women. This is particularly important as it may indicate 
a potential screening opportunity for individuals who present with TMD to a dental 
physician to explore a history of abuse, a discussion which recent literature suggests 
currently happens infrequently in this setting [18]. There are several, simple approaches 
which can be integrated into daily dental practice such as the AVDR approach; asking about 
abuse, validating it is not the survivor’s fault, documenting and referring appropriately [19]. 
These approaches have been shown to work effectively in dental settings putting minimal 
strain on clinicians [18]. Further work is still required in other cohorts to identify if this 
relationship persists elsewhere and further work is needed to explain the pathway behind 
this relationship. 
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Table 1: Baseline characteristics 
 
Baseline Characteristics (Standard Deviation or Percentage) 
  Exposed Group Unexposed Group 
Number of patients 18,547 74,188 
Follow-up period (person years) 2.2 (SD 2.3) 3.2 (SD 2.8) 
Age (years) 36.9 (SD 12.5) 36.9 (SD 12.5) 
Body mass index     
<25kg/m2 7,916 (42.7%) 32,330 (43.6%) 
25-30kg/m2 3,999 (21.6%) 16,346 (22.0%) 
>30kg/m2 3,568 (19.2%) 13,934 (18.8%) 
Not available 3,064 (16.5%) 11,578 (15.6%) 
Current Smoking status 8,096 (44.7%)  16,039 (21.6%) 
Drinking Status     
Non-drinker 5,149 (27.8%) 13,771 (18.6%) 
Drinker not excess 8,353 (45.0%) 44,112 (59.5%) 
Excessive drinker 1,870 (10.1%) 1,580 (2.1%) 
Not available 3,175 (17.1%) 14,725 (19.9%) 
Townsend index for deprivation     
(Least deprived) 1     1,773 (10.1%) 14,160 (20.2%) 
2 2,104 (12.0%) 12,881 (18.4%) 
3 3,149 (17.9%) 13,548 (19.3%) 
4 4,215 (24.0%) 12,601 (18.0%) 
5 4,266 (24.3%) 9,330 (13.3%) 
Not available 2,068 (11.8%) 7,691 (11.0%) 
Temporomandibular joint disorder at 
baseline 
  
TMD 343 (1.9%) 1,507 (2.0%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Risk of developing TMD following exposure to IPV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Adjusted Incidence rate ratio: adjusted for BMI, age, smoking status and Townsend deprivation index at 
baseline.  
 
  Temporomandibular Joint Disorder 
  Exposed Unexposed 
Number of Patients 18,204 72,681 
Numbers of Incident 
Outcomes 
94 342 
Person-years 59,138 282,410 
Incidence Rate (per 1000 
person years) 
1.59 1.21 
Unadjusted Incidence Rate 
Ratio (95% Confidence 
intervals) 
1.31 (1.04-1.65) 
p-value 0.020 
Adjusted Incidence Rate 
Ratio (95% Confidence 
intervals)* 
1.45 (1.14-1.84) 
p-value 0.002 
